CN106138759A - A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease - Google Patents
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease Download PDFInfo
- Publication number
- CN106138759A CN106138759A CN201610745522.3A CN201610745522A CN106138759A CN 106138759 A CN106138759 A CN 106138759A CN 201610745522 A CN201610745522 A CN 201610745522A CN 106138759 A CN106138759 A CN 106138759A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- pharmaceutical composition
- cerebrovascular disease
- treating cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease, including the raw material of following weight portion: Herb Gynostemmae Pentaphylli 20 40 parts, Sargassum 24 34 parts, Fructus Lycii 10 30 parts, Radix Et Caulis Acanthopanacis Senticosi 5 10 parts, Pheretima 1 10 parts, Herba Dendrobii 9 18 parts, 7 18 parts of Folium Mori, Semen Astragali Complanati 6 12 parts, Radix Cynanchi Paniculati 24 parts, Cornu Saigae Tataricae 15 parts, Fructus Corni 37 parts, Rhizoma Polygonati 12 20 parts, the Radix Paeoniae Alba 5 10 parts.Therapeutic effect of the present invention is good, and curative effect is high, instant effect, takes stopgap measures and effects a permanent cure, and is difficult to recurrence.
Description
Technical field
The present invention relates to pharmaceutical composition technical field, particularly relate to a kind of drug regimen preventing and treating cardiovascular and cerebrovascular disease
Thing.
Background technology
Along with the raising of people's living standard, rhythm of life is accelerated, family, cause pressure increasing, emotion also heals
Come more unstable；Meanwhile, excessive consumption of alcohol, taking in too many food fat, lack the motion of necessity, living environment is polluted in addition, empty
Anion concentration in gas declines, and causes taking in internal anion not enough, and these factors directly make human metabolism's speed
Slowing down, velocity of blood flow reduces, and blood viscosity raises, and result causes cerebral ischemia.Long-term hypertension can make cerebral artery vessel wall
Thickening or hardening, tube chamber attenuates.When blood pressure rises sharply, cerebrovascular is easily broken generation cerebral hemorrhage；Meanwhile, hypertension accelerates
The hardening process of tremulous pulse, arterial endothelial cell liquid sustains damage, and platelet is easily assembled in injury, without prevention in time, adjusts
Reason, it will cause the series cardiovascular and cerebrovascular disease such as coronary heart disease, cerebral thrombosis.A lot of Patients with Cardiovascular/Cerebrovascular Diseases obtain due to the most timely
To treatment, often leaving sequela, serious harm people's is healthy, the biggest burden caused to patient, family and society
Painful with the human body.At present, the method for the treatment of cardiovascular disease is with expansion blood vessel, reduction blood glucose viscosity, antiplatelet aggregation, anticoagulant
Blood etc. are main, and Chinese medicine and Western medicine all play respective effect.Tradition Western medicine is nitric acid lipid, beta-receptor resistance preparation, Ca2+ overloading
Agent etc., though onset is rapid, but all have certain toxic and side effects, should not take for a long time.Its indication of Chinese medicine compound preparation is the most single
One, it is impossible to meet the needs of clinical various cardiovascular and cerebrovascular disease, take effect slow, therapeutic effect is the best, we have proposed one for this
The pharmaceutical composition of preventing and treating cardiovascular and cerebrovascular disease, is used for solving the problems referred to above.
Summary of the invention
The technical problem existed based on background technology, the present invention proposes a kind of drug regimen preventing and treating cardiovascular and cerebrovascular disease
Thing.
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease that the present invention proposes, including the raw material of following weight portion: strand
Stock blue 20-40 part, Sargassum 24-34 part, Fructus Lycii 10-30 part, Radix Et Caulis Acanthopanacis Senticosi 5-10 part, Pheretima 1-10 part, Herba Dendrobii 9-18 part, Folium Mori
7-18 part, Semen Astragali Complanati 6-12 part, Radix Cynanchi Paniculati 2-4 part, Cornu Saigae Tataricae 1-5 part, Fructus Corni 3-7 part, Rhizoma Polygonati 12-20 part, Radix Paeoniae Alba 5-10
Part.
Preferably, including the raw material of following weight portion: Herb Gynostemmae Pentaphylli 25-35 part, Sargassum 26-32 part, Fructus Lycii 15-25 part,
Radix Et Caulis Acanthopanacis Senticosi 6-9 part, Pheretima 3-8 part, Herba Dendrobii 12-15 part, Folium Mori 9-16 part, Semen Astragali Complanati 8-10 part, Radix Cynanchi Paniculati 2.5-3.5 part, antelope
Cornu Caprae seu Ovis 2-4 part, Fructus Corni 4-6 part, Rhizoma Polygonati 14-18 part, Radix Paeoniae Alba 6-9 part.
Preferably, including the raw material of following weight portion: Herb Gynostemmae Pentaphylli 30 parts, Sargassum 29 parts, Fructus Lycii 20 parts, Radix Et Caulis Acanthopanacis Senticosi 7.5
Part, Pheretima 5 parts, Herba Dendrobii 13 parts, 13 parts of Folium Mori, Semen Astragali Complanati 9 parts, Radix Cynanchi Paniculati 3 parts, Cornu Saigae Tataricae 3 parts, Fructus Corni 5 parts, Rhizoma Polygonati 16
Part, the Radix Paeoniae Alba 7.5 parts.
Preferably, described Herb Gynostemmae Pentaphylli, Sargassum, the weight ratio of Fructus Lycii are 25-35:26-32:15-25.
Preferably, described Radix Et Caulis Acanthopanacis Senticosi, Pheretima, the weight ratio of Herba Dendrobii are 6-9:3-8:12-15.
Preferably, described Folium Mori, Semen Astragali Complanati, the weight ratio of Radix Cynanchi Paniculati are 9-16:8-10:2.5-3.5.
Preferably, the preparation method of described pharmaceutical composition comprises the following steps:
S1, weighs Herb Gynostemmae Pentaphylli, Sargassum, Fructus Lycii, Radix Et Caulis Acanthopanacis Senticosi, Pheretima according to deal proportioning, is mixed by above-mentioned raw materials, and
Putting in dehydrator and be dried, drying time is 40-50min, obtains dried object A；
S2, weighs Herba Dendrobii, Folium Mori, Semen Astragali Complanati, Radix Cynanchi Paniculati, Cornu Saigae Tataricae, Fructus Corni, Rhizoma Polygonati, the Radix Paeoniae Alba according to deal proportioning, by above-mentioned
Raw material mixes, and puts in dehydrator and be dried, and drying time is 30-60min, obtains dried object B；
S3, is mixed dried object A and dried object B, and is pulverized by pulverizer, crosses 120 mesh sieves, and makes granule, i.e.
Available a kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease.
In the present invention, Radix Cynanchi Paniculati can lower atherosclerosis with reducing blood pressure and blood fat, increases coronary flow, improves the heart
Flesh metabolism, alleviates myocardial ischemia；Rhizoma Polygonati can increase coronary flow and blood pressure lowering, and can blood fat reducing and alleviate coronary artery
Atherosis degree；The Radix Paeoniae Alba can release vascular smooth muscular spasm expansion peripheral blood vessel, slight blood pressure lowering antithrombus formation, increases the heart
Myotrophy blood flow；The all medicines of the present invention share, and can increase blood vessel elasticity, reduce blood pressure, and improve microcirculation, increase ischemia
The blood supply amount of tissue, reduces myocardial oxygen consumption, prevents and treat heart and brain tissues ischemia, limits and reduces heart and brain infraction model
Enclose, enhancing human body immunity function, reduce blood fat, suppression arteriosclerosis.Therapeutic effect of the present invention is good, and curative effect is high, instant effect, takes stopgap measures
Effect a permanent cure again, be difficult to recurrence.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is explained orally further.
Embodiment one
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease that the present invention proposes, including the raw material of following weight portion: Herb Gynostemmae Pentaphylli
20 parts, Sargassum 24 parts, Fructus Lycii 10 parts, Radix Et Caulis Acanthopanacis Senticosi 5 parts, Pheretima 1 part, Herba Dendrobii 9 parts, 7 parts of Folium Mori, Semen Astragali Complanati 6 parts, Radix Cynanchi Paniculati 2
Part, Cornu Saigae Tataricae 1 part, Fructus Corni 3 parts, Rhizoma Polygonati 12 parts, the Radix Paeoniae Alba 5 parts.
Its preparation method comprises the following steps:
S1, weighs Herb Gynostemmae Pentaphylli, Sargassum, Fructus Lycii, Radix Et Caulis Acanthopanacis Senticosi, Pheretima according to deal proportioning, is mixed by above-mentioned raw materials, and
Putting in dehydrator and be dried, drying time is 40min, obtains dried object A；
S2, weighs Herba Dendrobii, Folium Mori, Semen Astragali Complanati, Radix Cynanchi Paniculati, Cornu Saigae Tataricae, Fructus Corni, Rhizoma Polygonati, the Radix Paeoniae Alba according to deal proportioning, by above-mentioned
Raw material mixes, and puts in dehydrator and be dried, and drying time is 30min, obtains dried object B；
S3, is mixed dried object A and dried object B, and is pulverized by pulverizer, crosses 120 mesh sieves, and makes granule, i.e.
Available a kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease.
Embodiment two
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease that the present invention proposes, including the raw material of following weight portion: Herb Gynostemmae Pentaphylli
25 parts, Sargassum 26 parts, Fructus Lycii 15 parts, Radix Et Caulis Acanthopanacis Senticosi 6 parts, Pheretima 3 parts, Herba Dendrobii 12 parts, 9 parts of Folium Mori, Semen Astragali Complanati 8 parts, Radix Cynanchi Paniculati
2.5 parts, Cornu Saigae Tataricae 2 parts, Fructus Corni 4 parts, Rhizoma Polygonati 14 parts, the Radix Paeoniae Alba 6 parts.
Its preparation method comprises the following steps:
S1, weighs Herb Gynostemmae Pentaphylli, Sargassum, Fructus Lycii, Radix Et Caulis Acanthopanacis Senticosi, Pheretima according to deal proportioning, is mixed by above-mentioned raw materials, and
Putting in dehydrator and be dried, drying time is 42min, obtains dried object A；
S2, weighs Herba Dendrobii, Folium Mori, Semen Astragali Complanati, Radix Cynanchi Paniculati, Cornu Saigae Tataricae, Fructus Corni, Rhizoma Polygonati, the Radix Paeoniae Alba according to deal proportioning, by above-mentioned
Raw material mixes, and puts in dehydrator and be dried, and drying time is 35min, obtains dried object B；
S3, is mixed dried object A and dried object B, and is pulverized by pulverizer, crosses 120 mesh sieves, and makes granule, i.e.
Available a kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease.
Embodiment three
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease that the present invention proposes, including the raw material of following weight portion: Herb Gynostemmae Pentaphylli
30 parts, Sargassum 29 parts, Fructus Lycii 20 parts, Radix Et Caulis Acanthopanacis Senticosi 7.5 parts, Pheretima 5 parts, Herba Dendrobii 13 parts, 13 parts of Folium Mori, Semen Astragali Complanati 9 parts, Xu long
Minister in ancient times 3 parts, Cornu Saigae Tataricae 3 parts, Fructus Corni 5 parts, Rhizoma Polygonati 16 parts, the Radix Paeoniae Alba 7.5 parts.
Its preparation method comprises the following steps:
S1, weighs Herb Gynostemmae Pentaphylli, Sargassum, Fructus Lycii, Radix Et Caulis Acanthopanacis Senticosi, Pheretima according to deal proportioning, is mixed by above-mentioned raw materials, and
Putting in dehydrator and be dried, drying time is 45min, obtains dried object A；
S2, weighs Herba Dendrobii, Folium Mori, Semen Astragali Complanati, Radix Cynanchi Paniculati, Cornu Saigae Tataricae, Fructus Corni, Rhizoma Polygonati, the Radix Paeoniae Alba according to deal proportioning, by above-mentioned
Raw material mixes, and puts in dehydrator and be dried, and drying time is 45min, obtains dried object B；
S3, is mixed dried object A and dried object B, and is pulverized by pulverizer, crosses 120 mesh sieves, and makes granule, i.e.
Available a kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease.
Embodiment four
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease that the present invention proposes, including the raw material of following weight portion: Herb Gynostemmae Pentaphylli
35 parts, Sargassum 32 parts, Fructus Lycii 25 parts, Radix Et Caulis Acanthopanacis Senticosi 9 parts, Pheretima 8 parts, Herba Dendrobii 15 parts, 16 parts of Folium Mori, Semen Astragali Complanati 10 parts, Xu long
Minister in ancient times 3.5 parts, Cornu Saigae Tataricae 4 parts, Fructus Corni 6 parts, Rhizoma Polygonati 18 parts, the Radix Paeoniae Alba 9 parts.
Its preparation method comprises the following steps:
S1, weighs Herb Gynostemmae Pentaphylli, Sargassum, Fructus Lycii, Radix Et Caulis Acanthopanacis Senticosi, Pheretima according to deal proportioning, is mixed by above-mentioned raw materials, and
Putting in dehydrator and be dried, drying time is 48min, obtains dried object A；
S2, weighs Herba Dendrobii, Folium Mori, Semen Astragali Complanati, Radix Cynanchi Paniculati, Cornu Saigae Tataricae, Fructus Corni, Rhizoma Polygonati, the Radix Paeoniae Alba according to deal proportioning, by above-mentioned
Raw material mixes, and puts in dehydrator and be dried, and drying time is 50min, obtains dried object B；
S3, is mixed dried object A and dried object B, and is pulverized by pulverizer, crosses 120 mesh sieves, and makes granule, i.e.
Available a kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease.
Embodiment five
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease that the present invention proposes, including the raw material of following weight portion: Herb Gynostemmae Pentaphylli
40 parts, Sargassum 34 parts, Fructus Lycii 30 parts, Radix Et Caulis Acanthopanacis Senticosi 10 parts, Pheretima 10 parts, Herba Dendrobii 18 parts, 18 parts of Folium Mori, Semen Astragali Complanati 12 parts, slowly
Long minister in ancient times 4 parts, Cornu Saigae Tataricae 5 parts, Fructus Corni 7 parts, Rhizoma Polygonati 20 parts, the Radix Paeoniae Alba 10 parts.
Its preparation method comprises the following steps:
S1, weighs Herb Gynostemmae Pentaphylli, Sargassum, Fructus Lycii, Radix Et Caulis Acanthopanacis Senticosi, Pheretima according to deal proportioning, is mixed by above-mentioned raw materials, and
Putting in dehydrator and be dried, drying time is 50min, obtains dried object A；
S2, weighs Herba Dendrobii, Folium Mori, Semen Astragali Complanati, Radix Cynanchi Paniculati, Cornu Saigae Tataricae, Fructus Corni, Rhizoma Polygonati, the Radix Paeoniae Alba according to deal proportioning, by above-mentioned
Raw material mixes, and puts in dehydrator and be dried, and drying time is 60min, obtains dried object B；
S3, is mixed dried object A and dried object B, and is pulverized by pulverizer, crosses 120 mesh sieves, and makes granule, i.e.
Available a kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease.
Case 1: Ma, man, 51 years old, often there is dyspnea, suffer from hypertension, show myocardial ischemia through Electrocardioscopy,
Taking medicine of the present invention after 45 days, blood pressure is steady, and dyspnea symptom eliminates, and reexamines after taking 3 months, and Electrocardioscopy shows
Show cardiac muscle no longer ischemia.
Case 2: Lee, man, 44 years old, suffer from coronary heart disease, cardiac blood supply deficiency, take medicine of the present invention after 45 days, symptom
Being obviously improved, reexamine after taking 4 months, indices is normal.
Case 3: Wang, female, 61 years old, often have uncomfortable in chest, abundant expectoration, dizzy, vomiting and nausea is often made, and takes medicine of the present invention after 60 days,
Remission, reexamines after taking 4 months, transference cure.
The above, the only present invention preferably detailed description of the invention, but protection scope of the present invention is not limited thereto,
Any those familiar with the art in the technical scope that the invention discloses, according to technical scheme and
Inventive concept equivalent or change in addition, all should contain within protection scope of the present invention.
Claims (7)
1. the pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease, it is characterised in that include the raw material of following weight portion: Herb Gynostemmae Pentaphylli
20-40 part, Sargassum 24-34 part, Fructus Lycii 10-30 part, Radix Et Caulis Acanthopanacis Senticosi 5-10 part, Pheretima 1-10 part, Herba Dendrobii 9-18 part, Folium Mori 7-18
Part, Semen Astragali Complanati 6-12 part, Radix Cynanchi Paniculati 2-4 part, Cornu Saigae Tataricae 1-5 part, Fructus Corni 3-7 part, Rhizoma Polygonati 12-20 part, Radix Paeoniae Alba 5-10 part.
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease the most according to claim 1, it is characterised in that include following
The raw material of weight portion: Herb Gynostemmae Pentaphylli 25-35 part, Sargassum 26-32 part, Fructus Lycii 15-25 part, Radix Et Caulis Acanthopanacis Senticosi 6-9 part, Pheretima 3-8 part, stone
Dry measure used in former times 12-15 part, Folium Mori 9-16 part, Semen Astragali Complanati 8-10 part, Radix Cynanchi Paniculati 2.5-3.5 part, Cornu Saigae Tataricae 2-4 part, Fructus Corni 4-6 part, Huang
Essence 14-18 part, Radix Paeoniae Alba 6-9 part.
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease the most according to claim 1, it is characterised in that include following
The raw material of weight portion: Herb Gynostemmae Pentaphylli 30 parts, Sargassum 29 parts, Fructus Lycii 20 parts, Radix Et Caulis Acanthopanacis Senticosi 7.5 parts, Pheretima 5 parts, Herba Dendrobii 13 parts, Folium Mori
13 parts, Semen Astragali Complanati 9 parts, Radix Cynanchi Paniculati 3 parts, Cornu Saigae Tataricae 3 parts, Fructus Corni 5 parts, Rhizoma Polygonati 16 parts, the Radix Paeoniae Alba 7.5 parts.
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease the most according to claim 1, it is characterised in that described strand
Indigo plant, Sargassum, the weight ratio of Fructus Lycii are 25-35:26-32:15-25.
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease the most according to claim 1, it is characterised in that described thorn five
Add, Pheretima, the weight ratio of Herba Dendrobii are 6-9:3-8:12-15.
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease the most according to claim 1, it is characterised in that described Mulberry
Leaf, Semen Astragali Complanati, the weight ratio of Radix Cynanchi Paniculati are 9-16:8-10:2.5-3.5.
A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease the most according to claim 1, it is characterised in that described medicine
The preparation method of compositions comprises the following steps:
S1, weighs Herb Gynostemmae Pentaphylli, Sargassum, Fructus Lycii, Radix Et Caulis Acanthopanacis Senticosi, Pheretima according to deal proportioning, is mixed by above-mentioned raw materials, and
Putting in dehydrator and be dried, drying time is 40-50min, obtains dried object A；
S2, weighs Herba Dendrobii, Folium Mori, Semen Astragali Complanati, Radix Cynanchi Paniculati, Cornu Saigae Tataricae, Fructus Corni, Rhizoma Polygonati, the Radix Paeoniae Alba according to deal proportioning, by above-mentioned
Raw material mixes, and puts in dehydrator and be dried, and drying time is 30-60min, obtains dried object B；
S3, is mixed dried object A and dried object B, and is pulverized by pulverizer, crosses 120 mesh sieves, and makes granule, i.e.
Available a kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610745522.3A CN106138759A (en) | 2016-08-29 | 2016-08-29 | A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610745522.3A CN106138759A (en) | 2016-08-29 | 2016-08-29 | A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106138759A true CN106138759A (en) | 2016-11-23 |
Family
ID=57344821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610745522.3A Pending CN106138759A (en) | 2016-08-29 | 2016-08-29 | A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106138759A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109091636A (en) * | 2018-10-30 | 2018-12-28 | 右江民族医学院 | A kind of strong medicine composition and preparation method thereof for treating coronary heart disease |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972353A (en) * | 2010-10-15 | 2011-02-16 | 彭军 | Medicine composition for preventing and treating heart cerebrovascular diseases |
| CN102145128A (en) * | 2011-03-30 | 2011-08-10 | 呼伦贝尔松鹿制药有限公司 | Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
| CN104689232A (en) * | 2015-02-11 | 2015-06-10 | 代川山 | Traditional Chinese medicine composition for adjusting cardiovascular and cerebrovascular diseases |
-
2016
- 2016-08-29 CN CN201610745522.3A patent/CN106138759A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101972353A (en) * | 2010-10-15 | 2011-02-16 | 彭军 | Medicine composition for preventing and treating heart cerebrovascular diseases |
| CN102145128A (en) * | 2011-03-30 | 2011-08-10 | 呼伦贝尔松鹿制药有限公司 | Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
| CN104689232A (en) * | 2015-02-11 | 2015-06-10 | 代川山 | Traditional Chinese medicine composition for adjusting cardiovascular and cerebrovascular diseases |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109091636A (en) * | 2018-10-30 | 2018-12-28 | 右江民族医学院 | A kind of strong medicine composition and preparation method thereof for treating coronary heart disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101254272B (en) | Medicament for promoting coronary circulation and embolism resistance | |
| CN101011522B (en) | Chinese traditional medicine for treating cardiopathy | |
| CN102846955A (en) | Chinese herbal medicine heightening insole | |
| CN104758353A (en) | Medicine composition for treating cardiovascular diseases, preparation method and application thereof | |
| CN104069446A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
| CN106138759A (en) | A kind of pharmaceutical composition preventing and treating cardiovascular and cerebrovascular disease | |
| CN102836338B (en) | Chinese medicament for treating cardia-cerebrovascular diseases | |
| CN102908425A (en) | Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine | |
| CN100574800C (en) | A kind of Chinese patent medicine for the treatment of atherosclerosis of cardio-cerebral arteria and preparation method thereof | |
| CN103690643B (en) | A kind of medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof | |
| CN102406769B (en) | Traditional Chinese medicinal preparation for treating hypertension, hyperlipidemia, arteriosclerosis and coronary heart disease, and preparation method thereof | |
| CN1970050A (en) | Pharmaceutical composition for treating arrhythmia and preparation process thereof | |
| CN104522493A (en) | Health porridge for treating coronary atherosclerosis and preparation method of health porridge | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN101361855B (en) | Medicine for reducing and stabilizing blood-pressure | |
| CN103933290B (en) | Chinese medicine composition for the treatment of craniocerebral injury syndrome and preparation method thereof | |
| CN103055159B (en) | Medicine for treating hypertension | |
| CN101773590A (en) | Chinese drug capsule for treatment of coronary heart disease with qi deficiency and blood stasis | |
| CN101366910B (en) | Traditional Chinese medicine for treating frequent premature beat | |
| CN102406924B (en) | Medicine composition for treating cerebrovascular and cardiovascular diseases as well as preparation method and application thereof | |
| CN107854621A (en) | A kind of external Chinese medicinal oil for treating cardiovascular and cerebrovascular disease | |
| CN105983053B (en) | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method | |
| CN103655917B (en) | A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease | |
| CN103751616B (en) | Pharmaceutical composition for the treatment of autonomic nervous dysfunction and its production and use | |
| CN112972581A (en) | Shenfeng heart-calming composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161123 |
|
| RJ01 | Rejection of invention patent application after publication |